Skip to content
PICO Portalanswers from OpenAlex

Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial

PaperCitations, authors & open-access status

Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial is a paper indexed in PICO Portal from OpenAlex.

How many citations does Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial have?

PICO Portalcitation count

Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial has 6 citations in the OpenAlex counts PICO Portal stores.

When was Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial published?

PICO Portalyear

Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial has 2025 year in the PICO Portal index.

What is the open-access status of Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial?

PICO Portaloa status

Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial has hybrid oa status in the PICO Portal index.

What is the DOI of Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial?

PICO Portaldoi

The DOI for Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial is on the source record.

What is the PMID of Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial?

PICO Portalpmid

The PMID for Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial is on the source record.

What is the OpenAlex record for Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial?

PICO Portalopenalex

The OpenAlex for Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial